Functional Impact of Multi-omic Interactions in Breast Cancer Subtypes
Overview
Authors
Affiliations
Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promised mechanistic explanations have not quite settled yet. Here, we propose a theoretical and computational analysis framework to semi-automatically produce network models of the regulatory constraints influencing a biological function. This way, we identified functions significantly enriched on the analyzed omics and described associated features, for each of the four breast cancer molecular subtypes. For instance, we identified functions sustaining over-representation of invasion-related processes in the basal subtype and DNA modification processes in the normal tissue. We found limited overlap on the omics-associated functions between subtypes; however, a startling feature intersection within subtype functions also emerged. The examples presented highlight new, potentially regulatory features, with sound biological reasons to expect a connection with the functions. Multi-omic regulatory networks thus constitute reliable models of the way omics are connected, demonstrating a capability for systematic generation of mechanistic hypothesis.
Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors.
Rojas-Salazar Y, Gomez-Montanez E, Rojas-Salazar J, Anda-Jauregui G, Hernandez-Lemus E Int J Mol Sci. 2024; 25(23).
PMID: 39684551 PMC: 11641395. DOI: 10.3390/ijms252312840.
Velazquez-Caldelas T, Zamora-Fuentes J, Hernandez-Lemus E Front Immunol. 2024; 15:1357726.
PMID: 38983850 PMC: 11231215. DOI: 10.3389/fimmu.2024.1357726.
Functional impact of multi-omic interactions in lung cancer.
Diaz-Campos M, Vasquez-Arriaga J, Ochoa S, Hernandez-Lemus E Front Genet. 2024; 15:1282241.
PMID: 38389572 PMC: 10881857. DOI: 10.3389/fgene.2024.1282241.
Molecular mechanisms of multi-omic regulation in breast cancer.
Ochoa S, Hernandez-Lemus E Front Oncol. 2023; 13:1148861.
PMID: 37564937 PMC: 10411627. DOI: 10.3389/fonc.2023.1148861.
Southekal S, Shakyawar S, Bajpai P, Elkholy A, Manne U, Mishra N Cancers (Basel). 2023; 15(7).
PMID: 37046795 PMC: 10093233. DOI: 10.3390/cancers15072134.